Trademark Overview
On Thursday, April 3, 2025, a trademark application was filed for HARTENZUS with the United States Patent and Trademark Office. The USPTO has given the HARTENZUS trademark a serial number of 99119559. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 5, 2025. This trademark is owned by Merck Sharp & Dohme LLC. The HARTENZUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
